Results 71 to 80 of about 212,880 (258)
The Journal of Headache and Pain, 2019 Background and aimMonoclonal antibodies acting on the calcitonin gene-related peptide or on its receptor are new drugs to prevent migraine. Four monoclonal antibodies have been developed: one targeting the calcitonin gene-related peptide receptor ...
S. Sacco +6 more
semanticscholar +1 more source
American Heart Journal, 1972 Classical migraine, including incapacitating visual field defects, repeatedly developed in five young men immediately after blows to the head while playing football and in no other circumstances. A similar condition occurred in a professional boxer and an isolated attack in a boy footballer.
openaire +3 more sources
Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine.
New England Journal of Medicine, 2019 BACKGROUND Calcitonin gene-related peptide receptor has been implicated in the pathogenesis of migraine. Rimegepant is an orally administered, small-molecule, calcitonin gene-related peptide receptor antagonist that may be effective in acute migraine ...
R. Lipton +9 more
semanticscholar +1 more source
Seminars in Neurology, 2013 Vestibular migraine presents with attacks of spontaneous or positional vertigo, head motion-induced vertigo, and visual vertigo lasting 5 minutes to 3 days. The recent classification of vestibular migraine, jointly proposed by the Bárány Society and the International Headache Society, allows identification of vestibular migraine and probable vestibular
openaire +3 more sources
Diagnosis and Development of Screening Items for Migraine in Neurological Practice in Taiwan
Journal of the Formosan Medical Association, 2008 The objectives of this study were to: (1) survey migraine diagnoses among neurological outpatients in Taiwan; (2) compare neurologists’ migraine diagnoses with the International Classification of Headache Disorders 2nd Edition (ICHD-2) criteria; and (3 ...
Shuu-Jiun Wang +8 more
doaj +1 more source
European headache federation consensus on the definition of resistant and refractory migraine
The Journal of Headache and Pain, 2020 Introduction Despite advances in the management of headache disorders, some patients with migraine do not experience adequate pain relief with acute and preventive treatments.
S. Sacco +12 more
semanticscholar +1 more source
Global assessment of migraine severity measure: preliminary evidence of construct validity
BMC Neurology, 2019 Background In persons with migraine, severity of migraine is an important determinant of several health outcomes (e.g., patient quality of life and health care resource utilization).
Tolulope T. Sajobi +6 more
doaj +1 more source
Cephalalgia, 2020 Clinical trials are a key component of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Controlled ...
H. Diener +14 more
semanticscholar +1 more source
A Micro-Longitudinal Study of Naps, Sleep Disturbance, and Headache Severity in Women with Chronic Migraine [PDF]
, 2022 Jason C. Ong +10 more
openalex +1 more source
Australian Prescriber, 2020 Migraine causes significant lost time from everyday activities. Addressing lifestyle triggers and comorbidities in patients with migraine is the first step of management Acute migraine treatments primarily manage the headache component and should be started as early as possible in the migraine attack Prophylaxis may be recommended if a patient is ...
openaire +2 more sources